Purilogics

Clemson, United States Founded: 2013 • Age: 13 yrs Acquired By Donaldson Company
Technologies for biomolecule separation and purification are developed.

About Purilogics

Purilogics is a Healthcare company based in Clemson (United States) founded in 2013, and was acquired by Donaldson Company in June 2022. Technologies for biomolecule separation and purification are developed. Purilogics offers products and services including Purexaâ„¢ PrA, Purexaâ„¢ MCP, Purexaâ„¢ NAEX, and Purexaâ„¢ OdT. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its competitors include Amyris, Avidity Biosciences and Arbor Biotechnologies; 3 of its 3 listed competitors have raised funding.

Company details

Purilogics was founded in 2013 and is based in Clemson, United States. Technologies focused on the separation and purification of biomolecules are developed within the biotechnology sector. Operations center on prepacked columns compatible with chromatography systems. The portfolio includes Puri-Q and Puri-MQ for impurity removal during polishing steps, as well as Puri-MC and Puri-A for product recovery from cell culture supernatant.

  • Headquarters Clemson, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website purilogics.com
  • Social LinkedIn
  • Acquired by Donaldson Company (Jun 2022)
Key Metrics

Products & Services of Purilogics

Purilogics offers a comprehensive portfolio of products and services, including Purexa™ PrA, Purexa™ MCP, Purexa™ NAEX, and Purexa™ OdT.

Purexa™ PrA
Chromatography Membrane

Membrane for rapid antibody purification in biopharmaceuticals.

Purexa™ MCP
Chromatography Membrane

Technology for high-volume biologics polishing processes.

Purexa™ NAEX
Chromatography Membrane

Membrane solution for effective nucleic acid purification.

Purexa™ OdT
Chromatography Membrane

System for fast and consistent therapeutic production.

Funding Insights of Purilogics

  • Total Rounds 5
  • Last Round Grant — $1.19M
  • First Round $1.72M

    (Aug 2016)

  • Investors Count 1

All 5 funding rounds of Purilogics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2021$1.19MGrant––
Apr 2020$227,679Grant––
Apr 2019$218,744Grant––
Aug 2017$1.99MGrant––
Aug 2016$1.72MGrant––
Valuation history

2 investors in total: 2 institutional.

Investors in Purilogics

Purilogics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Donaldson Company and HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Filtration systems are manufactured and supplied globally by Donaldson Company.
1915donaldson.comGurugram, India
Premium access

Investor details for Purilogics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Purilogics

12 people are tracked at Purilogics (2 in leadership, 10 in team).

NameRoleGroup
Scott Husson
President & Co-FounderLeadership
Graham Temples
Associate Director of ResearchLeadership
Karsten Poulsen
Engineering ManagerTeam
Bin Guo
Manager Advanced R&DTeam
Emily Gessner
Associate ScientistTeam
Briannah Woodhams
Laboratory Technician IITeam
Roslynn Dwyer
Laboratory Technician IITeam
Ken Emme
Laboratory Technician IITeam
John O'Dell
Sr. Engineer TechTeam
Reagan Rodriguez
Laboratory Technician IITeam
Colleen Duncan-Hegic
ScientistTeam
Austin Bolt
Laboratory Technician IITeam
Premium access

Complete people profiles for Purilogics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Purilogics

4 dated milestones of Purilogics across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Purilogics is founded.
  2. Funding First funding round of $1.7M.
  3. Funding Latest funding round, Grant, of $1.2M.
  4. Exit Acquired by Donaldson Company.

Competitors of Purilogics

Purilogics has 3 listed competitors in our database, 3 of them funded. They include Amyris, Avidity Biosciences and Arbor Biotechnologies.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
amyris.com2003Emeryville, United States$487.2M747
Developer of renewable products for industrial solutions
aviditybiosciences.com2012San Diego, United States$142.54M253
Antibody-siRNA complexes are developed for cancer treatment.
arbor.bio2016Cambridge, United States$304.1M117
Genomic technologies and drug discovery platforms are provided.
Premium access

Detailed competitors of Purilogics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Purilogics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Purilogics

Premium access

Complete news archive for Purilogics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Purilogics

Purilogics was founded in 2013 and raised its 1st funding round 3 years after it was founded.

Purilogics is headquartered in Clemson, United States. It is registered at Clemson, South Carolina, United States.

Purilogics was founded in 2013 and is based in Clemson, United States. Technologies focused on the separation and purification of biomolecules are developed within the biotechnology sector. Operations center on prepacked columns compatible with chromatography systems. The portfolio includes Puri-Q and Puri-MQ for impurity removal during polishing steps, as well as Puri-MC and Puri-A for product recovery from cell culture supernatant.

Purilogics's top competitors include Avidity Biosciences, Arbor Biotechnologies and Amyris.

Purilogics offers Purexaâ„¢ PrA, Purexaâ„¢ MCP, Purexaâ„¢ NAEX, and Purexaâ„¢ OdT.

Purilogics has 2 investors. Key investors include Donaldson Company, and HHS.

Yes. Purilogics was acquired by Donaldson Company in June 2022.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available